Page last updated: 2024-10-29

iopromide and Nasopharyngeal Carcinoma

iopromide has been researched along with Nasopharyngeal Carcinoma in 1 studies

iopromide: structure given in first source
iopromide : A dicarboxylic acid diamide that consists of N-methylisophthalamide bearing three iodo substituents at positions 2, 4 and 6, a methoxyacetyl substituent at position 5 and two 2,3-dihydroxypropyl groups attached to the amide nitrogens. A water soluble x-ray contrast agent for intravascular administration.

Nasopharyngeal Carcinoma: A carcinoma that originates in the EPITHELIUM of the NASOPHARYNX and includes four subtypes: keratinizing squamous cell, non-keratinizing, basaloid squamous cell, and PAPILLARY ADENOCARCINOMA. It is most prevalent in Southeast Asian populations and is associated with EPSTEIN-BARR VIRUS INFECTIONS. Somatic mutations associated with this cancer have been identified in NPCR, BAP1, UBAP1, ERBB2, ERBB3, MLL2, PIK3CA, KRAS, NRAS, and ARID1A genes.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Yang, Q1
Mo, Y1
Zhao, Q1
Ban, X1
He, M1
Cai, P1
Liu, X1
Xie, C1
Zhang, R1

Other Studies

1 other study available for iopromide and Nasopharyngeal Carcinoma

ArticleYear
Radiation-induced sarcomas of the head and neck in post-radiation nasopharyngeal carcinoma.
    La Radiologia medica, 2017, Volume: 122, Issue:1

    Topics: Adult; Aged; Carcinoma; Contrast Media; Female; Gadolinium DTPA; Head and Neck Neoplasms; Humans; Io

2017